Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biol...

por Fagerli, Karen M, Kearsley-Fleet, Lianne, Mercer, Louise K, Watson, Kath, Packham, Jon, Symmons, Deborah P M, Hyrich, Kimme L
Publicado 2019

Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD)

por Mielnik, Pawel, Sexton, Joseph, Fagerli, Karen M, Bakland, Gunnstein, Hu, Yi, Kristianslund, Eirik K, Hoff, Mari, Wierød, Ada, Kvien, Tore K
Publicado 2023